Alnylam Pharmaceuticals
ALNY
#696
Rank
HK$284.51 B
Marketcap
HK$2,131
Share price
1.13%
Change (1 day)
-16.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company